Lotus International

What Lotus International does

Lotus International is a Mumbai-based pharmaceutical wholesale exporter founded in 1991 that distributes branded and generic pharmaceutical formulations to international buyers across CIS countries, Africa, Latin America, South East Asia, and the Middle East (UAE, Saudi Arabia, Oman, Qatar, Kuwait, Bahrain). The company maintains an extensive product catalog covering oncology drugs (Arimidex, Avastin, Herclon, Crizalk, Jevtana, Zytiga), vaccines (HPV, Hepatitis A/B, Rabies, Polio, MMR, Typhoid, Cholera, Rotavirus, Meningococcal, Pneumococcal), antidiabetics and weight-loss GLP-1 products (Rybelsus, Mounjaro, Wegovy), immunosuppressants (Sandimmun), antifungals (Ambisome), thrombolytics (Actilyse), pulmonary surfactants (Survanta), erectile dysfunction products, and veterinary medicines. Customers comprise pharmaceutical distributors, importers, hospitals, government procurement agencies, and NGOs in regulated and semi-regulated international markets.

The company's operational technology centers on pharmaceutical export logistics, including temperature-controlled cold chain handling for vaccines and a documentation apparatus producing Commercial Invoices, Packing Lists, Certificates of Origin, Certificates of Analysis, Batch Release Certificates, and Product Dossiers aligned to importing country requirements. Lotus International is ISO 9001:2015 certified and holds Indian Government recognized Two Star Export House status, with a documented quality management framework supporting cross-border trade. Operations are coordinated from a single headquarters in Goregaon, Mumbai, with global air and sea freight fulfillment.

Lotus International operates a B2B export model through direct enterprise sales and long-term channel partnerships with Indian pharmaceutical manufacturers. Pricing is quote-based rather than publicly disclosed, structured around minimum order quantities that vary by product category and destination. Revenue is generated through bulk wholesale transactions to distributors, hospitals, government procurement agencies, and NGOs. Customer acquisition combines a product-catalog website optimized for SEO with a direct export enquiry processing function, emphasizing stable long-term international supply relationships over one-time transactions. Leadership comprises founder and chairman Saraj Kumar with operational contacts Dr. Omprakash Jagnani, Mr. Purshottam Malsisaria, and Mr. Ashutosh Jagnani.

Name

Lotus International

Legal name

Lotus International

Website

https://lotusinternational.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

Lotus International is a Mumbai-based pharmaceutical wholesale exporter established in 1991 that distributes branded and generic formulations, including oncology drugs, vaccines, and GLP-1 antidiabetics, to distributors, hospitals, government agencies, and NGOs across CIS, Africa, Latin America, SE Asia, and the Middle East.

Ownership category

akta.pro rank

Headquarters

HQ city

Goregaon

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Wholesale Export: Wholesale distribution of branded and generic pharmaceutical formulations to international markets including oncology products, vaccines, Covid-19 products, specialty products, lifesaving drugs, erectile dysfunction products, and veterinary medicines. Revenue generated through bulk quantity sales to distributors, hospitals, government procurement agencies, and international importers.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Lotus International is a pharmaceutical wholesale exporter that sources branded and generic formulations from Indian manufacturers and supplies them in bulk to international distributors, hospitals, government procurement agencies, and NGOs. The company handles oncology products, vaccines, antidiabetics, immunosuppressants, antifungals, thrombolytics, and specialty pharmaceuticals with cold chain logistics and complete export documentation support across CIS, African, Latin American, South East Asian, and Middle East markets.

Product overview

Lotus International is a wholesale pharmaceutical exporter from India established in 1991, dealing in both branded and generic pharmaceutical products. The company offers a comprehensive portfolio of pharmaceutical formulations including oncology products (Arimidex, Avastin, Herclon, Crizalk, Jevtana, Zytiga), vaccines (Havrix, Engerix B, Twinrix, Cervarix, Gardasil, Fluarix, Varilrix, Rabipur, Verorab, Rotarix, Typhim VI, Typherix, Shanchol, BCG, Meningococcal vaccines, RhoGAM, DTP vaccines, Polio, MMR, Influenza, Pneumococcal, HPV), antidiabetic agents (Rybelsus, Mounjaro, Wegovy, Yurpeak KwikPen), immunosuppressants (Sandimmun), antifungals (Ambisome), thrombolytics (Actilyse), pulmonary surfactants (Survanta), topical antibiotics (Bactroban/T-Bact, Neosporin, Paraxin), topical corticosteroids (Betnesol, Dermanex), erectile dysfunction products (Penegra-XL Gel), and weight loss products. The company exports to CIS, African, Latin American, South East Asian, and Middle East countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Pharmaceuticals Portfolio Bulk wholesale supply of oncology pharmaceutical formulations including Arimidex (Anastrozole), Avastin (Bevacizumab), Herclon (Trastuzumab), Crizalk (Crizotinib), Jevtana (Cabazitaxel), and Zytiga (Abiraterone), supplied to international distributors, hospitals, and government procurement agencies for the treatment of breast, lung, colorectal, ovarian, and prostate cancers.
• Vaccines Portfolio Bulk export of vaccines including Havrix and Havpur (Hepatitis A), Engerix B (Hepatitis B), Twinrix (Hep A+B combined), Cervarix and Gardasil (HPV), Fluarix (Influenza), BCG Onco BP, Verorab and Rabipur (Rabies), Varilrix (Varicella), Typhim VI and Typherix (Typhoid), Rotarix (Rotavirus), Shanchol (Cholera), Quadrimeningo (Meningococcal), Tritanrix HB and Tripacel (DTP), Pentaxim, Infanrix, Priorix (MMR), Mencevax ACWY, RhoGAM, Hiberix, Imovax Polio, Okavax, Boostrix, Adacel, Act-Hib, Pneumovax, Pneumo 23, Prevenar, and SII Onco BCG, shipped with temperature-controlled cold chain logistics.
• Antidiabetic Medications Portfolio Bulk wholesale export of antidiabetic pharmaceutical products including Rybelsus (Semaglutide 3mg, 7mg, 14mg oral tablets), Mounjaro (Tirzepatide 2.5mg, 5mg injection), and Yurpeak KwikPen (Tirzepatide pre-filled pen), supplied to international distributors and healthcare institutions for management of type 2 diabetes.
• Wegovy (Semaglutide Weight Management Injection) Bulk export of Semaglutide injection (0.25mg to 2.4mg) for long-term weight management in adults with obesity and cardiovascular risk reduction; GLP-1 receptor agonist supplied to international distributors and healthcare providers.
• Sandimmun (Cyclosporin Immunosuppressant) Bulk export of Cyclosporin 100mg per ml Injection or drink solution (Sandimmun) supplied to international transplant centers, hospitals, and specialty distributors for preventing organ rejection after transplant and treating rheumatoid arthritis and psoriasis.
• Actilyse (Alteplase Thrombolytic Injection) Bulk export of Alteplase 20mg and 50mg Injection (Actilyse), a thrombolytic agent supplied to international hospitals and emergency care providers for treatment of acute ischaemic stroke, acute myocardial infarction, pulmonary embolism, and deep venous thrombosis.
• Ambisome (Liposomal Amphotericin B Antifungal) Bulk export of Liposomal Amphotericin B 50mg Injection (Ambisome) supplied to international hospitals and specialty distributors for treatment of fungal infections in febrile and neutropenic patients, cryptococcal meningitis, and visceral leishmaniasis.
• Survanta (Beractant Pulmonary Surfactant) Bulk export of Beractant 4ml and 8ml intratracheal suspension (Survanta), a natural bovine lung extract pulmonary surfactant supplied to international neonatal care units and hospitals for treatment of respiratory distress syndrome in premature infants.
• Penegra-XL Stimulating Gel Bulk export of Penegra-XL stimulating gel, a topical erectile dysfunction product with localized vasodilation effects, supplied to international distributors and pharmacies.

Quantifiable outcome

• Supplying pharmaceutical products to regulated and semi-regulated markets across 5+ regions globally

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Strides Pharma: Indian pharma company with explicit focus on exports to emerging markets (Africa, SE Asia, CIS). Closest peer to Lotus International's go-to-market of regulated and semi-regulated destinations via branded and generic formulations.
• Taj Pharmaceuticals: Indian pharmaceutical manufacturer and exporter with a similar model of supplying generics, oncology, and specialty formulations to international distributors, hospitals, and government buyers. Closest pure-play mid-sized comparator.

Broad incumbents

• Cipla: Major Indian generic-pharma manufacturer with deep emerging-market export presence including Africa and the Middle East. Comparable on geographic footprint and product breadth (oncology, respiratory, antiretrovirals).
• Lupin: Indian generic-pharma manufacturer with strong emerging-market presence. Comparable on cross-border distribution model and therapeutic-area breadth across cardiovascular, anti-infectives, and oncology.
• Biocon: Indian biopharmaceutical company focused on biosimilars, generics, and biologics with global export presence. Comparable in oncology biologics and insulin/GLP-1 adjacencies and in institutional buyer channels.
• Mankind Pharma: Large Indian pharma company expanding aggressively into OTC, generics, and exports. Comparable in product breadth across therapeutic categories and growing international footprint in similar emerging markets.
• Dr. Reddy's Laboratories: Indian pharma major exporting generics and biosimilars to emerging markets and regulated geographies. Comparable across oncology, vaccines, and chronic-disease portfolios served through distributor and institutional channels.
• Zydus Lifesciences: Indian pharma company with strong generics, biosimilars, and vaccines portfolio, exporting to emerging and regulated markets. Comparable across oncology, vaccines, and chronic-disease categories.
• Aurobindo Pharma: Large Indian pharmaceutical manufacturer and exporter with significant emerging-market distribution including Africa, CIS, and Latin America. Comparable because it competes for the same cross-border pharma trade flows that Lotus International serves, though at vastly greater scale and with captive manufacturing.

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharma manufacturer serving the Middle East and African markets. Comparable as a regional pharma supplier into similar buyer segments (hospitals, government procurement) in geographies Lotus International actively serves.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lotus-international

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lotus International